Pierre van der Bruggen

Pierre van der Bruggen

UNVERIFIED PROFILE

Are you Pierre van der Bruggen?   Register this Author

Register author
Pierre van der Bruggen

Pierre van der Bruggen

Publications by authors named "Pierre van der Bruggen"

Are you Pierre van der Bruggen?   Register this Author

71Publications

1603Reads

25Profile Views

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166.

Nat Commun 2020 Mar 19;11(1):1457. Epub 2020 Mar 19.

UCLouvain, Louvain Institute of Biomolecular Science and Technology, Group of Molecular Physiology, Croix du Sud 4-5, B-1348, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-020-15303-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081352PMC
March 2020

Protocol to assess the suppression of T-cell proliferation by human MDSC.

Methods Enzymol 2020 8;632:155-192. Epub 2019 Jul 8.

de Duve Institute, Université catholique de Louvain, Brussels, Belgium; WELBIO, Brussels, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.mie.2019.05.046DOI Listing
July 2019

Reverse immunology: From peptide sequence to tumor-killing human T-cell clones.

Methods Enzymol 2020 17;631:159-194. Epub 2019 Jun 17.

De Duve Institute, Université catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.mie.2019.05.033DOI Listing
June 2019

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.

Cancer Immunol Immunother 2019 Apr 21;68(4):631-644. Epub 2018 May 21.

Research Division, Department of Otorhinolaryngology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45122, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-018-2170-8DOI Listing
April 2019

The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP Dependent.

J Immunol 2019 01 17;202(2):451-459. Epub 2018 Dec 17.

Ludwig Institute for Cancer Research, Brussels B-1200, Belgium;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1800353DOI Listing
January 2019

Extracellular galectins as controllers of cytokines in hematological cancer.

Blood 2018 08 6;132(5):484-491. Epub 2018 Jun 6.

de Duve Institute, Université Catholique de Louvain, Brussels, Belgium; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-846014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073326PMC
August 2018

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

J Clin Oncol 2017 Oct 15;35(29):3322-3329. Epub 2017 Aug 15.

Yong-Chen Lu, Linda L. Parker, Tangying Lu, Zhili Zheng, Mary Ann Toomey, Donald E. White, Xin Yao, Yong F. Li, Paul F. Robbins, Steven A. Feldman, Christopher A. Klebanoff, Stephanie L. Goff, Richard M. Sherry, Udai S. Kammula, James C. Yang, and Steven A. Rosenberg, National Cancer Institute, Bethesda, MD; Pierre van der Bruggen, Ludwig Institute for Cancer Research; De Duve Institute, Université Catholique de Louvain, Brussels; and Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wallonia, Belgium; Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652397PMC
October 2017

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.

Nat Commun 2017 10 6;8(1):793. Epub 2017 Oct 6.

Ludwig Institute for Cancer Research, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, 1200, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-017-00925-6
Publisher Site
http://dx.doi.org/10.1038/s41467-017-00925-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630615PMC
October 2017

Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.

Histol Histopathol 2017 Aug 21;32(8):793-803. Epub 2016 Nov 21.

Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-11-847DOI Listing
August 2017

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.

Oncol Lett 2017 Mar 1;13(3):1609-1618. Epub 2017 Feb 1.

Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2017.5665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403542PMC
March 2017

Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells.

Part Fibre Toxicol 2016 08 23;13(1):46. Epub 2016 Aug 23.

Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Avenue Mounier 53 bte B1.52.12, 1200, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12989-016-0158-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994252PMC
August 2016

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.

J Immunother 2016 06;39(5):191-201

*Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD †Cellular Biomedicine Group Inc., Cupertino, CA ‡Ludwig Institute for Cancer Research and WELBIO §De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947411PMC
June 2016

Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.

J Immunol 2016 Feb 20;196(4):1711-20. Epub 2016 Jan 20.

Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium; de Duve Institute, Université Catholique de Louvain, Brussels B-1200, Belgium;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1501574DOI Listing
February 2016

Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice.

Nat Biotechnol 2015 Apr 16;33(4):402-7. Epub 2015 Mar 16.

1] Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. [2] Institute of Immunology, Charité Campus Buch, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.3147DOI Listing
April 2015

Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.

Mol Vis 2014 2;20:956-69. Epub 2014 Jul 2.

Ludwig Institute for Cancer Research and de Duve Institute, Université catholique de Louvain, 74 av. Hippocrate, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077848PMC
September 2014

Database of T cell-defined human tumor antigens: the 2013 update.

Cancer Immun 2013 15;13:15. Epub 2013 Jul 15.

Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718731PMC
May 2014

A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes.

Clin Cancer Res 2014 Apr 13;20(7):1823-33. Epub 2014 Feb 13.

Authors' Affiliations: Ludwig Institute for Cancer Research Brussels and WELBIO; de Duve Institute; Departments of Gynecology and Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain; Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Medical School of the Vrije Universiteit Brussel, Brussels; and Department of Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/20/7/1823.full
Web Search
http://clincancerres.aacrjournals.org/content/early/2014/02/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-2459DOI Listing
April 2014

Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins.

Oncoimmunology 2014 29;3:e28783. Epub 2014 Apr 29.

Ludwig Institute for Cancer Research Brussels; WELBIO; and de Duve Institute; Université Catholique de Louvain; Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.28783
Publisher Site
http://dx.doi.org/10.4161/onci.28783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091051PMC
April 2014

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Nat Rev Cancer 2014 Feb;14(2):135-46

1] de Duve Institute and the Université catholique de Louvain, B-1200 Brussels, Belgium. [2] Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3670DOI Listing
February 2014

TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.

Clin Dev Immunol 2012 12;2012:586314. Epub 2012 Feb 12.

Laboratory of Experimental Tumor Immunology, Department of Medical Oncology, Erasmus MC, 3015 GE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/586314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287115PMC
March 2013

Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.

Mol Ther 2012 May 28;20(5):1063-74. Epub 2012 Feb 28.

Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Medical School of the Vrije Universiteit Brussel (VUB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2012.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345975PMC
May 2012

Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation.

J Biol Chem 2012 Mar 13;287(14):11240-51. Epub 2012 Feb 13.

Division of Molecular Biosciences, Imperial College London, London SW7 2AZ, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M111.320820DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322850PMC
March 2012

Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.

Cancers (Basel) 2011 Jul 18;3(3):2904-54. Epub 2011 Jul 18.

Ludwig Institute for Cancer Research and Université catholique de Louvain, de Duve Institute, 74 av. Hippocrate, P.O. Box B1-7403, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers3032904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759179PMC
July 2011

Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.

Int J Cancer 2010 Oct;127(7):1625-36

Ludwig Institute for Cancer Research Ltd, Brussels branch, and Université Catholique de Louvain, 74 avenue Hippocrate, UCL7459, B1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.25182
Publisher Site
http://dx.doi.org/10.1002/ijc.25182DOI Listing
October 2010

Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.

Clin Cancer Res 2009 May 5;15(10):3366-75. Epub 2009 May 5.

Laboratory of Molecular and Cellular Therapy, Department of Physiology-Immunology, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2982DOI Listing
May 2009

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

Cancer Res 2009 May 12;69(10):4335-45. Epub 2009 May 12.

Université Catholique de Louvain, Ludwig Institute for Cancer Research Ltd, Vrije Universiteit Brussel, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-3726DOI Listing
May 2009

Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.

Immunity 2008 Mar;28(3):414-24

Ludwig Institute for Cancer Research, 1200 Brussels, Belgium; Cellular Genetics Unit, Institute of Cellular Pathology, Université catholique de Louvain, 1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2008.01.011DOI Listing
March 2008

[General principles and first clinical trials of therapeutic vaccines against cancer].

Bull Cancer 2008 Mar;95(3):327-35

Centre du Cancer, Cliniques universitaires Saint-Luc, Oncology Department, 54 avenue Hippocrate, B-1200 Bruxelles, Belgique.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2008.0588DOI Listing
March 2008

CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation.

Blood 2006 Nov 20;108(9):2897-905. Epub 2006 Jul 20.

Ludwig Institute for Cancer Research, 74 avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-11-007237DOI Listing
November 2006

A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A24 carcinoma cells.

Cancer Immunol Immunother 2006 Jul 3;55(7):867-72. Epub 2005 Sep 3.

Ludwig Institute for Cancer Research and Institute of Cellular Pathology, Cellular Genetics Unit, Université de Louvain, 74 avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00262-005-0053
Web Search
http://link.springer.com/10.1007/s00262-005-0053-2
Publisher Site
http://dx.doi.org/10.1007/s00262-005-0053-2DOI Listing
July 2006

A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors.

Cancer Immunol Immunother 2006 Jun 27;55(6):644-52. Epub 2005 Sep 27.

Ludwig Institute for Cancer Research Institute of Cellular Pathology, Cellular Genetics Unit, Université de Louvain, 74 avenue Hippocrate, UCL 7459, 1200, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0066-xDOI Listing
June 2006

Human T cell responses against melanoma.

Annu Rev Immunol 2006 ;24:175-208

Ludwig Institute for Cancer Research, Brussels Branch, and Cellular Genetics Unit, Université de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.immunol.24.021605.090733DOI Listing
June 2006

Processing and presentation of tumor antigens and vaccination strategies.

Curr Opin Immunol 2006 Feb 15;18(1):98-104. Epub 2005 Dec 15.

Ludwig Institute for Cancer Research and Cellular Genetics Unit, Institute of Cellular Pathology, Université catholique de Louvain, 74 avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2005.11.013DOI Listing
February 2006

A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.

Cancer Immunol Immunother 2005 Dec 16;54(12):1214-20. Epub 2005 Jul 16.

Ludwig Institute for Cancer Research and Cellular Genetics Unit, University of Louvain, 74 avenue Hippocrate, UCL 74.59, 1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0705-2DOI Listing
December 2005

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

Mol Ther 2004 Oct;10(4):768-79

Laboratory of Molecular and Cellular Therapy, Department of Physiology-Immunology, Medical School of the Vrije Universiteit Brussel, Laarbeeklaan 103/E, 1090 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152500160401346
Publisher Site
http://dx.doi.org/10.1016/j.ymthe.2004.07.017DOI Listing
October 2004

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.

Proc Natl Acad Sci U S A 2004 Oct 27;101 Suppl 2:14631-8. Epub 2004 Sep 27.

Ludwig Institute for Cancer Research, Brussels Branch of Human Cell Genetics, Université de Louvain, 74 Avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0405743101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC521999PMC
October 2004

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

J Immunol 2004 Jun;172(11):6649-57

Laboratory of Molecular and Cellular Therapy, Department of Physiology-Immunology, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/content/172/11/6649.full.pdf
Web Search
http://dx.doi.org/10.4049/jimmunol.172.11.6649DOI Listing
June 2004

An antigenic peptide produced by peptide splicing in the proteasome.

Science 2004 Apr 4;304(5670):587-90. Epub 2004 Mar 4.

Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université de Louvain, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://www.sciencemag.org/cgi/doi/10.1126/science.1095522
Publisher Site
http://dx.doi.org/10.1126/science.1095522DOI Listing
April 2004

Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses.

J Immunol 2004 Feb;172(4):2232-7

Department of Physiology and Immunology, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.4.2232DOI Listing
February 2004

A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16.

Cancer Immun 2003 Dec 10;3:17. Epub 2003 Dec 10.

Ludwig Institute for Cancer Research, 74 avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://archive.cancerimmunity.org/v3p17/031118.pdf
Web Search
December 2003

Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.

Cancer Res 2003 Sep;63(17):5587-94

Laboratory of Molecular and Cellular Therapy, Department of Physiology-Immunology, Medical School of the Vrije Universiteit Brussel, 1090 Brussels, Belgium.

View Article

Download full-text PDF

Source
September 2003

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.

J Gene Med 2003 Aug;5(8):654-67

Department of Physiology and Immunology, Medical School of the Vrije Universiteit Brussel (VUB), Laarbeeklaan 103/E, 1090 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.400DOI Listing
August 2003

T-cell responses of vaccinated cancer patients.

Curr Opin Immunol 2003 Apr;15(2):131-7

Cellular Genetics Unit, Christian de Duve Institute of Cellular Pathology, Université de Louvain, Avenue Hippocrate 74, UCL 7459, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0952-7915(03)00009-8DOI Listing
April 2003

New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile.

Eur J Hum Genet 2002 Dec;10(12):833-40

Institut de Génétique Humaine, CNRS UPR 1142, 141, rue de la Cardonille, 34396 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.ejhg.5200891DOI Listing
December 2002

Tumor-specific shared antigenic peptides recognized by human T cells.

Immunol Rev 2002 Oct;188:51-64

Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université de Louvain, 74 avenue Hippocrate UCL 74.59, B-1200 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-065x.2002.18806.xDOI Listing
October 2002

YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway.

Mol Microbiol 2002 Aug;45(3):805-15

Microbial Pathogenesis Unit, Christian de Duve, Institute of Cellular Pathology and Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2958.2002.03053.xDOI Listing
August 2002